Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy

2022-09-15Executive Order 14081
Signed by: Joseph R. Biden Jr.
Share:

Headline: Federal Agencies Ordered to Expand America's Biotechnology and Biomanufacturing

What it does: Agencies must coordinate a whole-of-government initiative to expand biotech research, domestic biomanufacturing, data sharing, biosafety, and economic and national security protections for the bioeconomy.

Real World Impact:
  • Creates new reporting and planning requirements across multiple federal agencies.
  • Pushes to increase domestic biomanufacturing capacity and biobased product procurement.
  • Raises standards for biological data security, biosafety, and international cooperation.
Topics: biotechnology policy, biomanufacturing, workforce development, biosecurity, data protection

Summary

This order creates a National Biotechnology and Biomanufacturing Initiative to coordinate federal efforts to grow the U.S. bioeconomy. It directs agencies to boost research, expand domestic biomanufacturing, improve biological data access, and strengthen biosafety, biosecurity, and cybersecurity.

It requires agencies to produce reports and plans, set procurement and training goals, and review regulations to make oversight clearer. The order aims to protect U.S. technology leadership, support workforce development, and ensure biotechnology benefits are equitable and sustainable.

Ask about this order

Ask questions about this executive order and its implications.

What agencies are affected by this order?

How does this order change existing policy?

What are the practical implications of this order?

Related Executive Orders